亞信科技(01675.HK):獲納入恆生綜合指數系列及深港通合資格股份
格隆匯 9 月 7日丨亞信科技(01675.HK)宣佈,根據恆生指數有限公司於2020年8月14日公佈的恆生指數系列季度檢討結果,公司獲恆生指數有限公司選為以下指數系列成份股,該變動已於今日起生效:
1. 恆生港股通指數
2. 恆生港股通中國內地公司指數
3. 恆生港股通中國科技指數
4. 恆生互聯網科技業指數
5. 恆生港股通非AH股公司指數
根據深圳證券交易所近日發佈的《關於深港通下的港股通股票名單調整的公告》,根據《深圳證券交易所深港通業務實施辦法》的有關規定,公司獲納入深股通股票名單,並自2020年9月7日起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.